Menfil Orellana-Barrios is a Cardiology physician. OpenAlex indexes 39 publications with 449 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1150 State Highway 248 Ste 200
Branson, MO 656164186
Telephone
417-336-4112Provider last certified this registry record 21 Sept 2022.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20258 payments
- Boston Scientific CorporationProgram year20255 payments
- Abbott LaboratoriesProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.7%Beta blocker22.6%Metoprolol Succinate46%Carvedilol36%Metoprolol Tartrate7%Nebivolol Hcl7%Atenolol3%Sotalol1%Part D<11 patientsStatin16.7%Rosuvastatin Calcium48%Atorvastatin Calcium41%Pravastatin Sodium10%Lovastatin2%Part D<11 patients+ 16 more classes in this area
Blood & clotting
14.1%Factor Xa inhibitor8.4%Eliquis84%Xarelto17%Part D≥88 patientsP2Y12 inhibitor5.4%Clopidogrel77%Brilinta23%Part D≥70 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.8%SGLT2 inhibitor2.9%Jardiance76%Farxiga24%Part D<11 patientsPotassium supplement1.1%Potassium Chloride80%Klor-Con M2020%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Radial To Peripheral: The Efficacy of Transradial Access for Peripheral Interventions in Patients With Complex Transfemoral Access
Cardiovascular revascularization medicine
2021 - CRT-200.12 Radial to Peripheral Angiography and Interventions: A Case Series
JACC: Cardiovascular Interventions
2020 - Left atrial appendage closure for stroke risk reduction in patients with non-valvular atrial fibrillation and high bleeding risk–The Watchman Device
The Southwest Respiratory and Critical Care Chronicles
2020 - CRT-200.06 Utilization of EKOS (Ultrasound-Accelerated Thrombolysis) in the Treatment of Acute Limb Ischemia
JACC: Cardiovascular Interventions
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”